24.300
−0,82%
2026-10-19
Fundamental Analysis
59 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +33.7% | +15.1% | 2 / 3 | +34.6% | +0.61 pp | -0.22 pp | — | 0.03 | 4.69 | 370 | +34,6% | 107 | +33,6% | 4.69 | 7.58 | −38,1% |
| Pts | 8 | 0 | 8 | 12 | 8 | 4 | 0 | 12 | 12 | |||||||
Valuation annotation:Price: 24.300 (close price on 2026-10-19)EPS (TTM): 5.179
Financial charts
1.Revenue & growth
VND bn370Q2/26
1.Revenue & growth
VND bn370Q2/26
2.Profit & growth
VND bn107Q2/26
3.Profit mix (Penman)
VND bn406Q2/26
4.Margins & cost structure
%23.8%Q2/26
5.Returns & cash cycle
% · days13.7%Q2/26
6.Earnings quality & cash
VND bn292Q2/26
7.Asset structure
VND bn2.403Q2/26
8.Funding & debt health
VND bn · times2.403Q2/26
9.Revenue backlog
VND bn1,99Q2/26
10.Valuation
times · %4,7×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %1.590Q2/26
Adjusted EPS growth, latest quarter
33.7%
Average adjusted EPS growth, 3 quarters
15.1%
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26